Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics

Authors:

Abstract
Triosephosphate isomerase (TPI) deficiency is a poorly understood disease characterized by hemolytic anemia, cardiomyopathy, neurologic dysfunction, and early death. TPI deficiency is one of a group of diseases known as glycolytic enzymopathies, but is unique for its severe patient neuropathology and early mortality. The disease is caused by missense mutations and dysfunction in the glycolytic enzyme, TPI. Previous studies have detailed structural and catalytic changes elicited by disease-associated TPI substitutions, and samples of patient erythrocytes have yielded insight into patient hemolytic anemia; however, the neuropathophysiology of this disease remains a mystery. This study combines structural, biochemical, and genetic approaches to demonstrate that perturbations of the TPI dimer interface are sufficient to elicit TPI deficiency neuropathogenesis. The present study demonstrates that neurologic dysfunction resulting from TPI deficiency is characterized by synaptic vesicle dysfunction, and can be attenuated with catalytically inactive TPI. Collectively, our findings are the first to identify, to our knowledge, a functional synaptic defect in TPI deficiency derived from molecular changes in the TPI dimer interface. Glycolysis is the metabolic pathway that cells use to break down the sugar glucose, and mutations in the genes that control the glycolytic pathway elicit a collection of diseases known as glycolytic enzymopathies. Glycolytic enzymopathies are rare genetic diseases that lead to the degeneration of patient red blood cells. Triosephosphate isomerase is a gene that encodes a part of this glycolytic process, and patients with mutations in this gene experience the typical blood disorder, as well as severe neurologic dysfunction and often infant death. Until now, a molecular source of neurologic dysfunction in triosephosphate isomerase mutants was unknown. We have discovered that mutations that disrupt the self-association of the triosephosphate isomerase enzyme lead to neurologic dysfunction in fruit flies. This neurologic dysfunction is characterized by the abnormal cycling of neuronal vesicles that contain neurotransmitters. Given the evolutionary conservation of triosephosphate isomerase and neuronal synaptic function, we believe that these observations represent the dysfunction seen in human patients.

This publication has 98 references indexed in Scilit: